Journal
THEORETICAL MEDICINE AND BIOETHICS
Volume 32, Issue 4, Pages 229-243Publisher
SPRINGER
DOI: 10.1007/s11017-011-9179-8
Keywords
Placebo response; Nocebo effect; Informed consent; Risk-benefit assessment
Categories
Funding
- Intramural NIH HHS Funding Source: Medline
Ask authors/readers for more resources
It has been presumed within bioethics that the benefits and risks of treatments can be assessed independently of information disclosure to patients as part of the informed consent process. Research on placebo and nocebo effects indicates that this is not true for symptomatic treatments. The benefits and risks that patients experience from symptomatic treatments can be shaped powerfully by information about these treatments provided by clinicians. In this paper we discuss the implications of placebo and nocebo research for risk-benefit assessment and informed consent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available